Robert Aspbury
Vermogen: 2 M $ op 30-06-2026
Vermogen: 2 M $ op 30-06-2026
Robert P.
Aspbury is President-Certara Predictive Technologies at Certara, Inc. since 2020.
Formerly, Dr. Aspbury was Vice President-Strategic Solutions at Labcorp Drug Development, Inc. from 2016 to 2019.
Dr. Aspbury earned a doctorate from The University of Liverpool in 1995.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CERTARA, INC. 0,21% | 11-05-2026 | 332.442 ( 0,21% ) | 2 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| CERTARA, INC. | Corporate Officer/Principal | 01-01-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| COVANCE INC. | Corporate Officer/Principal | 01-03-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Labcorp Drug Development, Inc.
Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Certara, Inc.
Certara, Inc. Packaged SoftwareTechnology Services Develops bio simulation software and technology to transform traditional drug discovery and development | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau